Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

[Effects of rhubarb on the intestinal barrier function of patients with acute myocardial infarction-heart].

Mao XB, Wang SQ, Mao Y.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012 Aug;32(8):1046-50. Chinese.

PMID:
23173250
2.

Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.

Sanders-van Wijk S, Maeder MT, Nietlispach F, Rickli H, Estlinbaum W, Erne P, Rickenbacher P, Peter M, Pfisterer MP, Brunner-La Rocca HP; TIME-CHF Investigators.

Circ Heart Fail. 2014 Jan;7(1):131-9. doi: 10.1161/CIRCHEARTFAILURE.113.000527. Epub 2013 Dec 18.

3.

Effect of atorvastatin on plasma NT-proBNP and inflammatory cytokine expression in patients with heart failure.

Duan HY, Liu DM, Qian P, Wang SL, Yan LJ, Wu JT, Yang HT, Fan XW, Chu YJ.

Genet Mol Res. 2015 Dec 2;14(4):15739-48. doi: 10.4238/2015.December.1.25.

4.

N-terminal pro-B-type natriuretic peptide in risk stratification after acute myocardial infarction in patients on long-term beta-adrenergic receptor blocker therapy.

Jonsson G, Abdelnoor M, Landaas S, Muller C, Kjeldsen SE, Os I, Westheim A.

Cardiology. 2006;106(2):102-8. Epub 2006 Apr 21.

PMID:
16636540
5.

Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy.

van Diepen S, Newby LK, Lopes RD, Stebbins A, Hasselblad V, James S, Roe MT, Ezekowitz JA, Moliterno DJ, Neumann FJ, Reist C, Mahaffey KW, Hochman JS, Hamm CW, Armstrong PW, Granger CB, Theroux P; APEX AMI Investigators.

Int J Cardiol. 2013 Oct 3;168(3):2127-33. doi: 10.1016/j.ijcard.2013.01.004. Epub 2013 Feb 8.

PMID:
23394896
6.

[Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].

Huiling L, Yaping L, Xiufen H.

Zhonghua Er Ke Za Zhi. 2015 Apr;53(4):300-3. Chinese.

PMID:
26182507
7.

Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.

Khan SQ, Ng K, Dhillon O, Kelly D, Quinn P, Squire IB, Davies JE, Ng LL.

Eur Heart J. 2009 May;30(9):1057-65. doi: 10.1093/eurheartj/ehn600. Epub 2009 Jan 23.

PMID:
19168526
8.

Prognostic Significance of NT-proBNP Levels in Patients over 65 Presenting Acute Myocardial Infarction Treated Invasively or Conservatively.

Drewniak W, Szybka W, Bielecki D, Malinowski M, Kotlarska J, Krol-Jaskulska A, Popielarz-Grygalewicz A, Konwicka A, Dąbrowski M.

Biomed Res Int. 2015;2015:782026. doi: 10.1155/2015/782026. Epub 2015 Oct 11.

10.

Cystatin C, NT-proBNP, and inflammatory markers in acute heart failure: insights into the cardiorenal syndrome.

Lassus JP, Harjola VP, Peuhkurinen K, Sund R, Mebazaa A, Siirilä-Waris K, Miettinen K, Punnonen KR, Melin J, Pulkki K, Nieminen MS; FINN-AKVA study group.

Biomarkers. 2011 Jun;16(4):302-10. doi: 10.3109/1354750X.2011.555822. Epub 2011 Mar 21.

PMID:
21417622
11.

NT-ProBNP in outpatients after myocardial infarction: interaction between symptoms and left ventricular function and optimized cut-points.

Luchner A, Hengstenberg C, Löwel H, Buchner S, Schunkert H, Riegger GA, Holmer S.

J Card Fail. 2005 Jun;11(5 Suppl):S21-7.

PMID:
15948096
12.

Effects of ivabradine therapy on heart failure biomarkers.

Ordu S, Yildiz BS, Alihanoglu YI, Ozsoy A, Tosun M, Evrengul H, Kaftan HA, Ozhan H.

Cardiol J. 2015;22(5):501-9. doi: 10.5603/CJ.a2015.0012. Epub 2015 Mar 3.

PMID:
25733317
13.

Comparative value of BNP and NT-proBNP in diagnosis of heart failure.

Fonseca C, Sarmento PM, Minez A, Gonçalves E, Covas R, Dias AR, Pina MJ, Ceia F.

Rev Port Cardiol. 2004 Jul-Aug;23(7-8):979-91. English, Portuguese.

14.

Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.

Sirithunyanont C, Leowattana W, Sukumalchantra Y, Chaisupamonkollarp S, Watanawaroon S, Chivatanaporn B, Bhuripanyo K, Mahanonda N.

J Med Assoc Thai. 2003 May;86 Suppl 1:S87-95.

PMID:
12866774
15.

[Effect of blood activating water relieving method on heart functions and serum levels of NT-proBNP in patients with heart failure with normal ejection fraction].

Zou GL, Zhong WL, Sui YB, Jin J, Liu L.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014 Feb;34(2):146-8. Chinese.

PMID:
24672935
16.

High N-terminal pro-B-type natriuretic peptide levels are associated with reduced heart rate variability in acute myocardial infarction.

Lorgis L, Moreau D, Mock L, Daumas B, Potard D, Touzery C, Cottin Y, Zeller M.

PLoS One. 2012;7(10):e44677. doi: 10.1371/journal.pone.0044677. Epub 2012 Oct 12.

17.

Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP.

Luchner A, Hengstenberg C, Löwel H, Riegger GA, Schunkert H, Holmer S.

Hypertension. 2005 Jul;46(1):118-23. Epub 2005 Jun 6.

18.

N-terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal function.

Luchner A, Hengstenberg C, Löwel H, Trawinski J, Baumann M, Riegger GA, Schunkert H, Holmer S.

Hypertension. 2002 Jan;39(1):99-104.

19.

No effect of n-3 fatty acids supplementation on NT-proBNP after myocardial infarction: the Alpha Omega Trial.

Hoogeveen EK, Geleijnse JM, Kromhout D, van't Sant P, Gemen EF, Kusters R, Giltay EJ.

Eur J Prev Cardiol. 2015 May;22(5):648-55. doi: 10.1177/2047487314536694. Epub 2014 May 30.

PMID:
24879357
20.

Comparison of long-term prognostic value of N-terminal-proBNP and midregional-pro-adrenomedullin in patients with acute myocardial infarction.

Walter T, Brueckmann M, Lang S, Sauer T, Fiedler E, Papassotiriou J, Behnes M, Elmas E, Borggrefe M, Bertsch T.

Clin Lab. 2010;56(7-8):303-9.

PMID:
20857894

Supplemental Content

Support Center